News

Every day oncology pharmacists make a difference in the lives of cancer patients around the world. Part of ISOPP’s mission is to support and reward this vital work. We do this through our Awards program.

If you missed submitting an abstract for ISOPP’s International Virtual Symposium 2026, there is still time until Sunday, November 9, 2025.

We are delighted to announce that abstract submissions for the 2026 Virtual Symposium are now open!

The ISOPP Education Committee has been busy over the last few weeks. We are excited to share some highlights of what members can look out for in the coming weeks.

Members are invited to participate in the Highlights of ISOPP CAPhO Symposium 2025 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO) and produced in collaboration with the International Society of Oncology Pharmacy Practitioners (ISOPP), the British Oncology Pharmacists Association (BOPA), and the Clinical Oncology Society of Australia – Clinical Pharmacists Group (COSA CPG).

I’m excited to share that the 2026 ISOPP International Symposium 2026 is now open for abstract submissions! This 24-hour virtual event takes place on March 20, 2026, and will bring together oncology pharmacy profe

HOPA has graciously invited all ISOPP members to contribute to the HOPA Book - Letters from Oncology Pharmacists Worldwide

This week, the global oncology pharmacy leaders met to discuss pressing challenges and explore collaborative solutions that can impact cancer care worldwide

As Chair of the Compassion Fatigue Webinar Series, I’m pleased to share a brief reflection on the meaningful conversations we hosted this past June.

The growing use of oral chemotherapy in cancer care presents a significant opportunity to improve patient convenience and enable more treatment to be administered at home. This is particularly beneficial for patients who live far from specialised cancer centres, reducing travel time and logistical burden on both patients and caregivers.

We are proud to share that several ISOPP members from the ISOPP Advocacy committee, chaired by Esin Kandemir, played a pivotal role in shaping the 25th WHO Expert Committee on the Selection and Use of Essential Medicines report.

A joint statement from UICC and ISOPP on the alarming findings reported in The Lancet Global Health that reveal approximately one in six anticancer medication samples collected from public hospitals and private pharmacies across multiple countries in sub-Saharan Africa failed to meet international pharmaceutical standards.